More interestingly, resistance to EGFR TKIs in NSCLC is mainly mediated via the acquisition of the EGFR T790M gatekeeper mutation (~ 60%) [17], and we have shown here that getting rid of USP17 can trigger apoptosis of NSCLC cells with this mutation. The gene discussed is USP17L2; the disease is non-small cell lung carcinoma.